webinar register page

Webinar banner
Using Patholytix AI to Identify Signs of Drug Toxicity in Preclinical Safety Assessment Studies
Identification of drug toxicity is a critically important step in the drug development process, and is essential for progression to clinical trials. Preclinical Safety Assessment Studies rely on Pathologist scoring to identify these signs, but some toxicity lesions can be challenging to reliably identify.

In this webinar, we discuss the capabilities of Patholytix AI to assist pathologists in their preclinical workflows. In such workflows, slides need to be rapidly screened for the presence of several potential lesions of interest. Here, we discuss one specific lesion, hepatocellular hypertrophy, which can be rapidly and reliably identified using our well established AI algorithm. We also discuss its relevance to identifying other signs of toxicity, and how this tool, as part of our AI service, can be implemented to streamline pathologist workflows and give confidence in results.

Jul 27, 2022 04:00 PM in London

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: AI Services.